Table 1.
Characteristics of the vaccinated cohort.
| Characteristics | mRNA-1273 | BNT162b2 | p-Value |
|---|---|---|---|
| Volunteers, n | 68 | 82 | |
| Age (years), mean (SEM) | 47.85 (± 1.38) | 46.52 (± 1.36) | 0.495 |
| Days between 2nd dose and first extraction, median (range) | 27 (24–28) | 31 (23–40) | |
| Days between 2nd dose and second extraction, median (range) | 241 (227–266) | 246 (225–279) | |
| Gender, n (%) | 0.275 | ||
| Male | 14 (20.6) | 11 (13.4) | |
| Female | 54 (79.4) | 71 (86.6) | |
| Ethnicity, n (%) | 1.000 | ||
| Caucasian | 65 (95.6) | 78 (95.1) | |
| Latin-American | 3 (4.4) | 4 (4.9) | |
| Comorbidities, n (%) | |||
| Hyperthyroidism | 0 (0.0) | 1 (1.2) | 0.469 |
| Hypothyroidism | 5 (7.4) | 1 (1.2) | 0.091 |
| Hypertension | 5 (7.4) | 3 (3.6) | 1.000 |
| Dyslipidemia | 3 (4.4) | 4 (4.8) | 1.000 |
| Hypercholesterolemia | 0 (0.0) | 2 (2.4) | 0.501 |
| Diabetes | 0 (0.0) | 1 (1.2) | 1.000 |
| Pulmonary disease | 5 (7.4) | 2 (2.4) | 0.245 |
Characteristics of the cohort vaccinated with mRNA-1273 or BNT162b2 on days 30 and 240. Listed are the number of patients for each vaccine and characteristics such as age (expressed as mean ± SEM), gender (expressed as number of patients with each characteristic, and in asterisks, the percentage over the total number of patients for each cohort), ethnicity, and comorbidities. Also listed are the median number of days between the first and second dose and the days of blood sample extraction. The two-sample t-test was used for the comparison of age, and Fisher’s exact test for the rest of the characteristics. p-value < 0.05 indicates statistical difference between groups. SEM, standard error of the mean.